• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INNOVA; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INNOVA; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Model Number 26921
Device Problem Defective Device (2588)
Patient Problems No Consequences Or Impact To Patient (2199); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/13/2021
Event Type  Injury  
Event Description
It was reported the stent was shortened.A 5mm x 150mm x 130cm innova was selected for a procedure in the occluded superficial femoral artery.Pre-dilation was performed with a 4mm x 150mm balloon.When the stent was implanted, it was found to be shorter than the lesion length.A 5mm x 40mm innova was additionally implanted.There were no patient complications reported the patient was stable post procedure.
 
Manufacturer Narrative
Device eval by manufacturer: returned product consisted of an innova self-expanding stent system.The stent did not return for analysis as it was implanted.The outer sheath, tip, inner sheath, and the remainder of the device were checked for damage.Visual examination revealed a kink to the outer sheath at the nosecone.The distal section of the pull rack was separated inside the handle.The proximal section of the separated pull rack was missing.Microscopic examination revealed no additional damages.Inspection of the remainder of the device revealed no other damage or irregularities.
 
Event Description
It was reported the stent was shortened.A 5mm x 150mm x 130cm innova was selected for a procedure in the occluded superficial femoral artery.Pre-dilation was performed with a 4mmx150mm balloon.When the stent was implanted, it was found to be shorter than the lesion length.A 5mm x 40mm innova was additionally implanted.There were no patient complications reported the patient was stable post procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INNOVA
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key11230842
MDR Text Key228696804
Report Number2134265-2021-00795
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 02/17/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/10/2023
Device Model Number26921
Device Catalogue Number26921
Device Lot Number0025690539
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/01/2021
Initial Date Manufacturer Received 01/15/2021
Initial Date FDA Received01/26/2021
Supplement Dates Manufacturer Received02/03/2021
Supplement Dates FDA Received02/17/2021
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age75 YR
Patient Weight75
-
-